# FDA Inspection 1263856 - QuVa Pharma, Inc. - April 04, 2025

Source: https://www.keypedia.com/records/fda_inspections/quva-pharma-inc/259a7990-3b8e-4a0e-a0dc-9e9775b09d44
Source feed: FDA_Inspections

> FDA Inspection 1263856 for QuVa Pharma, Inc. on April 04, 2025. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1263856
- Company Name: QuVa Pharma, Inc.
- Inspection Date: 2025-04-04
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1181531 - 2022-10-14](https://www.keypedia.com/records/fda_inspections/quva-pharma-inc/778f28d6-99c1-496e-a459-f584b73a0745)
- [FDA Inspection 1094744 - 2019-05-31](https://www.keypedia.com/records/fda_inspections/quva-pharma-inc/59bffd82-fe85-49e1-bb9b-c11c65c5849e)
- [FDA Inspection 1032363 - 2017-11-30](https://www.keypedia.com/records/fda_inspections/quva-pharma-inc/41fbc22e-37e0-4057-b95d-f3701e59c7b6)

Company: https://www.keypedia.com/companies/quva-pharma-inc/1852735f-efbc-4896-9ba0-465f07d479e6

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248